Now showing items 1-1 of 1

    Issue DateTitleAuthor(s)
    27 April 2021Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients  Isaacson, SH; Ballard, CG; Kreitzman, DL; et al.